UMM Institutional Repository

STUDI PENGGUNAAN OBAT ANTI TUBERKULOSIS (OAT) KATEGORI 1 TERHADAP PASIEN TUBERKULOSIS PARU TAHAP LANJUTAN (Penelitian Dilakukan di Rumah Sakit Umum Daerah dr.Mohammad Zyn Sampang)

Arif, Annisa Qurrota Aulia (2019) STUDI PENGGUNAAN OBAT ANTI TUBERKULOSIS (OAT) KATEGORI 1 TERHADAP PASIEN TUBERKULOSIS PARU TAHAP LANJUTAN (Penelitian Dilakukan di Rumah Sakit Umum Daerah dr.Mohammad Zyn Sampang). Undergraduate (S1) thesis, University of Muhammadiyah Malang.

[img]
Preview
Text
PENDAHULUAN 01-.pdf

Download (867kB) | Preview
[img]
Preview
Text
BAB I.pdf

Download (378kB) | Preview
[img]
Preview
Text
BAB II.pdf

Download (748kB) | Preview
[img]
Preview
Text
BAB III.pdf

Download (210kB) | Preview
[img]
Preview
Text
BAB IV.pdf

Download (215kB) | Preview
[img] Text
BAB V.pdf
Restricted to Registered users only

Download (268kB) | Request a copy
[img] Text
BAB VI.pdf
Restricted to Registered users only

Download (232kB) | Request a copy
[img] Text
BAB VII.pdf
Restricted to Registered users only

Download (255kB) | Request a copy
[img] Text
LAMPIRAN 03-.pdf
Restricted to Registered users only

Download (2MB) | Request a copy

Abstract

Background: Tuberculosis is the second most common cause of death after HIV, and emerged as a major public health problem today. Tuberculosis is caused by infection with dissemination mycrobacterium tuberculosis primarily through the air. Objective : The study is to determine the pattern of therapy and the use of anti-tuberculosis drug in patients with pulmonary tuberculosis in first category continued phase. Research methods: The study was observational, descriptive, and retrospectively by processing the patient medical record. The total population is 140 people, with a sample of 20 people. Results and conclusions: Patterns of use anti-tuberculosis first category continued phase in 20 patients is given in 2 Type anti-tuberculosis, ie anti-tuberculosis separated and anti-tuberculosis FDC. Patients with anti-tuberculosis FDC usage patterns as many as 3 people (15%), and the use of anti-tuberculosis separated as many as 17 people (85%). The use of anti-tuberculosis FDC used is 1x2 tablet 2FDC 4(H3R3) of 1 person (33%) and 1x3 tablet 2FDC 4(H3R3) for 2 people (67%). The use of anti-tuberculosis separated as many as 17 people (100%) with the dose administered Rifampin = 450mg / 300mg Isoniazid = 4 (H3R3). The use of anti-tuberculosis in combination with other antibiotics at 1 (100%) is 1x3 tablet 2FDC 4 (H3R3) + Cefadroxil (2 x 500 mg) PO. The pattern of the highest switching therapy in the study include anti-tuberculosis FDC be anti-tuberculosis separated in 2 (67%). The use of anti-tuberculosis in dr.Mohammad Zyn Sampang hospitals are in accordance with the guidelines. Keywords: Anti-Tuberculosis, Tuberculosis Pulmonary, Continued Phase

Item Type: Thesis (Undergraduate (S1))
Student ID: 201410410311019
Thesis Advisors: Hidajah Rachmawati, Didik Hasmono
Keywords: Anti-Tuberculosis, Tuberculosis Pulmonary, Continued Phase
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Health Science > Department of Pharmacy (48201)
Depositing User: 201410410311019
Date Deposited: 13 Aug 2019 07:40
Last Modified: 13 Aug 2019 07:40
URI : http://eprints.umm.ac.id/id/eprint/48708

Actions (login required)

View Item View Item
UMM Official

© 2008 UMM Library. All Rights Reserved.
Jl. Raya Tlogomas No 246 Malang East Java Indonesia - Phone +62341464318 ext. 150, 151 - Fax +62341464101
E-Mail : infopus[at]umm.ac.id - Website : http://lib.umm.ac.id - Online Catalog : http://laser.umm.ac.id - Repository : http://eprints.umm.ac.id

Web Analytics

UMM Institutional Repository is powered by :
EPrints Logo